Michael Trang (M Trang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Multidrug Resistant

Cardiovascular Events

Extracorporeal Membrane Oxygenation

Community Acquired Pneumonia

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Kathryn Liolios, Michael Trang, Christopher M Rubino, Judith N Steenbergen, Lawrence Friedrich, Evan Tzanis, Paul G Ambrose
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections. Antimicrobial agents and chemotherapy (2024)
A J Lepak, Michael Trang, J P Hammel, Helio Silva Sader, Sujata M Bhavnani, Brian D VanScoy, J M Pogue, Paul G Ambrose, David R Andes, null null
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial agents and chemotherapy (2023)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Michael Trang, Justin C Bader, Catharine C Bulik, Brian D VanScoy, Christopher M Rubino, Michael D Huband, Lawrence Friedrich, Judith N Steenbergen, Paul G Ambrose
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial agents and chemotherapy (2023)
Michael Trang, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics. Antimicrobial agents and chemotherapy (2023)
Sujata M Bhavnani, Michael Trang, David C Griffith, Olga Lomovskaya, J P Hammel, J S Loutit, S K Cammarata, M N Dudley, Paul G Ambrose, Christopher M Rubino
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Antimicrobial agents and chemotherapy (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)